<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Atrial <z:mpath ids='MPATH_66'>dilatation</z:mpath> and atrial standstill are etiologically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> phenotypes with poorly defined nosology </plain></SENT>
<SENT sid="1" pm="."><plain>In 1983, we described 8-years follow-up of atrial <z:mpath ids='MPATH_66'>dilatation</z:mpath> with standstill evolution in 8 patients from 3 families </plain></SENT>
<SENT sid="2" pm="."><plain>We later identified 5 additional patients with identical phenotypes: 1 member of the largest original family and 4 unrelated to the 3 original families </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> families are from the same geographic area in Northeast Italy </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: We followed up the 13 patients for up to 37 years, extended the clinical investigation and monitoring to living relatives, and investigated the genetic basis of the disease </plain></SENT>
<SENT sid="5" pm="."><plain>The disease was characterized by: (1) clinical <z:hpo ids='HP_0003581'>onset in adulthood</z:hpo>; (2) biatrial <z:mpath ids='MPATH_66'>dilatation</z:mpath> up to giant size; (3) early <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> with progressive loss of atrial electric activity to atrial standstill; (4) thromboembolic complications; and (5) stable, <z:mpath ids='MPATH_458'>normal</z:mpath> left ventricular function and New York Heart Association functional class during the long-term course of the disease </plain></SENT>
<SENT sid="6" pm="."><plain>By linkage analysis, we mapped a locus at 1p36.22 containing the Natriuretic <z:chebi fb="7" ids="16670">Peptide</z:chebi> Precursor A gene </plain></SENT>
<SENT sid="7" pm="."><plain>By sequencing Natriuretic <z:chebi fb="7" ids="16670">Peptide</z:chebi> Precursor A, we identified a homozygous missense mutation (p.Arg150Gln) in <z:hpo ids='HP_0000001'>all</z:hpo> living affected individuals of the 6 families </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients showed low serum levels of atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Heterozygous mutation carriers were healthy and demonstrated <z:mpath ids='MPATH_458'>normal</z:mpath> levels of atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0000007'>Autosomal recessive</z:hpo> atrial <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e> associated with homozygous mutation of the Natriuretic <z:chebi fb="7" ids="16670">Peptide</z:chebi> Precursor A gene and characterized by extreme atrial <z:mpath ids='MPATH_66'>dilatation</z:mpath> with standstill evolution, thromboembolic risk, preserved left ventricular function, and severely decreased levels of atrial natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
</text></document>